As of May 23, 2025, Intelgenx Technologies Corp has a Discounted Cash Flow (DCF) derived fair value of $0.00 per share. With the current market price at $0.24, this represents a potential upside of -597.3%.
Key Metrics | Value |
---|---|
DCF Fair Value (5-year) | $0.00 |
DCF Fair Value (10-year) | $0.00 |
Potential Upside (5-year) | -606.6% |
Potential Upside (10-year) | -597.3% |
Discount Rate (WACC) | 5.9% - 10.4% |
Revenue is projected to grow from $1 million in 12-2023 to $1 million by 12-2033, representing a compound annual growth rate of approximately 0.0%.
Fiscal Year | Revenue (USD millions) | Growth |
---|---|---|
12-2023 | 1 | 9% |
12-2024 | 1 | 7% |
12-2025 | 1 | 2% |
12-2026 | 1 | 2% |
12-2027 | 1 | 7% |
12-2028 | 1 | 4% |
12-2029 | 1 | 3% |
12-2030 | 1 | 4% |
12-2031 | 1 | 3% |
12-2032 | 1 | 2% |
12-2033 | 1 | 2% |
Net profit margin is expected to improve from -955% in 12-2023 to -670% by 12-2033, driven by operational efficiency and economies of scale.
Fiscal Year | Net Profit (USD millions) | Profit Margin |
---|---|---|
12-2023 | (10) | -955% |
12-2024 | (8) | -696% |
12-2025 | (8) | -690% |
12-2026 | (8) | -685% |
12-2027 | (8) | -680% |
12-2028 | (9) | -675% |
12-2029 | (9) | -674% |
12-2030 | (9) | -673% |
12-2031 | (10) | -672% |
12-2032 | (10) | -671% |
12-2033 | (10) | -670% |
with a 5-year average of $0 million. Projected CapEx is expected to maintain at approximately 26% of revenue.
Depreciation is based on an average useful life of 5 years for capital assets.
Fiscal Year | D&A (USD millions) |
---|---|
12-2024 | 0 |
12-2025 | 0 |
12-2026 | 0 |
12-2027 | 0 |
12-2028 | 0 |
12-2029 | 0 |
Net working capital is expected to increase gradually, with projected changes affecting free cash flow.
Components | Average Days |
---|---|
Days Receivables | 217 |
Days Inventory | 12 |
Days Payables | 0 |
Fiscal Year | EBITDA | Tax | CapEx | Change in NWC | FCF |
---|---|---|---|---|---|
9M/2024 | (6) | (2) | 0 | 0 | (5) |
2025 | (9) | (3) | 0 | 0 | (6) |
2026 | (9) | (3) | 0 | (0) | (6) |
2027 | (9) | (3) | 0 | 0 | (7) |
2028 | (10) | (3) | 0 | 0 | (7) |
Valuation Method | Fair Price (USD) | Potential Upside |
---|---|---|
5-Year DCF (Growth) | 0.00 | -606.6% |
10-Year DCF (Growth) | 0.00 | -597.3% |
5-Year DCF (EBITDA) | 0.00 | -100.0% |
10-Year DCF (EBITDA) | 0.00 | -100.0% |
Is Intelgenx Technologies Corp (IGX.TO) a buy or a sell? Intelgenx Technologies Corp is definitely a sell. Based on our DCF analysis, Intelgenx Technologies Corp (IGX.TO) appears to be overvalued with upside potential of -597.3%. The company's strong projected growth in revenue and profitability, coupled with consistent capital expenditure, supports our positive outlook on its intrinsic value.
Key investment drivers include:
Investors should consider reducing exposure at the current market price of $0.24.